227 related articles for article (PubMed ID: 16770124)
1. Botulinum toxin in urinary incontinence.
Patterson JM; Chapple CR
Curr Opin Urol; 2006 Jul; 16(4):255-60. PubMed ID: 16770124
[TBL] [Abstract][Full Text] [Related]
2. Botulinum toxin for the treatment of lower urinary tract symptoms: a review.
Sahai A; Khan M; Fowler CJ; Dasgupta P
Neurourol Urodyn; 2005; 24(1):2-12. PubMed ID: 15578628
[TBL] [Abstract][Full Text] [Related]
3. Persistence of therapeutic effect after repeated injections of botulinum toxin type A to treat incontinence due to neurogenic detrusor overactivity.
Karsenty G; Reitz A; Lindemann G; Boy S; Schurch B
Urology; 2006 Dec; 68(6):1193-7. PubMed ID: 17141831
[TBL] [Abstract][Full Text] [Related]
4. Clinical effects of suburothelial injection of botulinum A toxin on patients with nonneurogenic detrusor overactivity refractory to anticholinergics.
Kuo HC
Urology; 2005 Jul; 66(1):94-8. PubMed ID: 15992869
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of botulinum toxin-A for treating idiopathic detrusor overactivity: results from a single center, randomized, double-blind, placebo controlled trial.
Sahai A; Khan MS; Dasgupta P
J Urol; 2007 Jun; 177(6):2231-6. PubMed ID: 17509328
[TBL] [Abstract][Full Text] [Related]
6. Botulinum toxin A for overactive bladder and detrusor muscle overactivity in patients with Parkinson's disease and multiple system atrophy.
Giannantoni A; Rossi A; Mearini E; Del Zingaro M; Porena M; Berardelli A
J Urol; 2009 Oct; 182(4):1453-7. PubMed ID: 19683298
[TBL] [Abstract][Full Text] [Related]
7. Effects of botulinum toxin B on refractory detrusor overactivity: a randomized, double-blind, placebo controlled, crossover trial.
Ghei M; Maraj BH; Miller R; Nathan S; O'Sullivan C; Fowler CJ; Shah PJ; Malone-Lee J
J Urol; 2005 Nov; 174(5):1873-7; discussion 1877. PubMed ID: 16217327
[TBL] [Abstract][Full Text] [Related]
8. Intravesical injection of botulinum toxin for the treatment of overactive bladder.
Ho MH; Lin LL; Haessler AL; Bhatia NN
Curr Opin Obstet Gynecol; 2005 Oct; 17(5):512-8. PubMed ID: 16141766
[TBL] [Abstract][Full Text] [Related]
9. Has botulinum toxin therapy come of age: what do we know, what do we need to know, and should we use it?
da Silva CM; Cruz F
Curr Opin Urol; 2009 Jul; 19(4):347-52. PubMed ID: 19444121
[TBL] [Abstract][Full Text] [Related]
10. The use of botulinum toxin A injection for the management of external sphincter dyssynergia in neurologically normal children.
Franco I; Landau-Dyer L; Isom-Batz G; Collett T; Reda EF
J Urol; 2007 Oct; 178(4 Pt 2):1775-9; discussion 1779-80. PubMed ID: 17707430
[TBL] [Abstract][Full Text] [Related]
11. Use of botulinum toxin for genitourinary conditions: What is the evidence?
da Silva CM; Chancellor MB; Smith CP; Cruz F
Toxicon; 2015 Dec; 107(Pt A):141-7. PubMed ID: 26235907
[TBL] [Abstract][Full Text] [Related]
12. Prospects and limitations of treatment with botulinum neurotoxin type A for patients with refractory idiopathic detrusor overactivity.
Schmid DM; Roy S; Sulser T; Scheiner D
BJU Int; 2008 Jul; 102 Suppl 1():7-10. PubMed ID: 18665972
[TBL] [Abstract][Full Text] [Related]
13. Use of botulinum toxin in the treatment of lower urinary tract disorders. Current status.
Mangera A; Chapple CR
Arch Esp Urol; 2010 Dec; 63(10):829-41. PubMed ID: 21187564
[TBL] [Abstract][Full Text] [Related]
14. Botulinum A toxin in the treatment of neurogenic detrusor overactivity: a consolidated field of application.
Giannantoni A; Mearini E; Del Zingaro M; Santaniello F; Porena M
BJU Int; 2008 Jul; 102 Suppl 1():2-6. PubMed ID: 18665971
[TBL] [Abstract][Full Text] [Related]
15. Botulinum toxin: a potential alternative to current treatment of neurogenic and idiopathic urinary incontinence due to detrusor overactivity.
Casanova N; McGuire E; Fenner DE
Int J Gynaecol Obstet; 2006 Dec; 95(3):305-11. PubMed ID: 17070528
[TBL] [Abstract][Full Text] [Related]
16. [Patient follow-up after botulinum toxin intradetrusor injection. Proposal for management in neurogenic patients].
de Sèze M; Ruffion A; Haab F; Chartier-Kastler E; Denys P; Game X; Karsenty G; Kerdraon J; Perrouin-Verbe B; Saussine C; Soler JM; Amarenco G
Ann Readapt Med Phys; 2008 May; 51(4):315-21. PubMed ID: 18514963
[TBL] [Abstract][Full Text] [Related]
17. [Injections of botulinum toxin a into the detrusor vesicae for treatment of refractory detrusor hyperactivity in non-neurological patients].
Neugart F; Groh R; Götz T; Horsch R
Aktuelle Urol; 2006 May; 37(3):212-7. PubMed ID: 16733825
[TBL] [Abstract][Full Text] [Related]
18. Do repeat intradetrusor botulinum toxin type a injections yield valuable results? Clinical and urodynamic results after five injections in patients with neurogenic detrusor overactivity.
Reitz A; Denys P; Fermanian C; Schurch B; Comperat E; Chartier-Kastler E
Eur Urol; 2007 Dec; 52(6):1729-35. PubMed ID: 17884281
[TBL] [Abstract][Full Text] [Related]
19. Botulinum toxin injection for lower urinary tract dysfunction.
Kuo YC; Kuo HC
Int J Urol; 2013 Jan; 20(1):40-55. PubMed ID: 22571329
[TBL] [Abstract][Full Text] [Related]
20. Six-year follow-up of botulinum toxin A intradetrusorial injections in patients with refractory neurogenic detrusor overactivity: clinical and urodynamic results.
Giannantoni A; Mearini E; Del Zingaro M; Porena M
Eur Urol; 2009 Mar; 55(3):705-11. PubMed ID: 18814955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
